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Abstract 
Background: Here we assessed the incidence of Influenza-A-H1N1-related pneumonia in community-acquired 
pneumonia (CAP) at Loghman Hakim Hospital, Tehran, Iran. 
Materials and Methods: In this prospective study from November 22, 2016, to June 21, 2017, patients with 
CAP and suspected to seasonal influenza were included. Rapid Antigen test and quantitative real-time PCR 
assay were performed on samples. P-value < 0.05 was considered significant. In addition, radiologic patterns of 
them were evaluated. 
Results: a total of 29 admitted CAP patients were suspected of seasonal influenza. Two cases out of them 
were positive for influenza by real-time PCR, similar to result of influenza rapid test. The most common 
finding in their chest X ray was consolidation in one lobe. None of them vaccinated against influenza. Only 
nine patients received empiric Oseltamivir treatment. The amount of irrational antibiotic administration was 
significant. 
Conclusion: Despite low statistical numbers, admitted influenza CAP patients did not have unusual symptoms 
and radiologic patterns. Other results in this study showed need for antibiotic stewardship program and better 
training about necessity of vaccination.  
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Community-acquired pneumonia (CAP) is an acute 
infection of the pulmonary parenchyma in a patient 
who has obtained the disease from the community. 
Community-acquired pneumonia is distinguished by; 
cough, fever, chills, fatigue, dyspnea, rigors and 
pleuritic chest pain (with or without new infiltrate on 
chest radiography), which attained outside of a 
hospital or long-term care facility1-3. 
Most cases of influenza are diagnosed based on 
clinical grounds. In some situations, the diagnosis of 
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influenza will be confirmed by some laboratory tests 
such as rapid test, PCR or cell culture4. Influenza is 
an acute respiratory disease that affects the upper 
and/or lower respiratory tracts and is usually 
associated with systemic signs and symptoms 
including fever, weakness, myalgia and headache5. 
According to Mandell’s principles and practice of 
infectious disease 2015, pulmonary complications  of  
influenza consist of primary viral pneumonia, 
secondary bacterial pneumonia, mixed viral and 
bacterial pneumonia and localized viral pneumonia4. 
Diagnosis of influenza is based on detecting the virus 
in throat and nasopharyngeal swabs, washes  or 
sputum. The most sensitive and specific test is 
reverse transcriptase polymerase chain reaction (RT-
PCR) that can differentiates influenza subtypes. The 
virus can be isolated by culture but this method is 
labored and is no longer used for diagnosis. The most 
common diagnostic method is rapid tests that detects 
viral antigens with relative specificity and variable 
sensitivity.  Using nasal swab is easy and painless, 
and it is feasible everywhere with no additional 
devices. There are no significant differences in 
sensitivity for nasal swab and nasopharyngeal 
aspirates when a sensitive method like PCR is being 
used for virus detection6.  
The overall rate of CAP in adults was estimated 1.07-
1.2/1000 in Europe7, 24.8/10,000 in America8 and 
780/1000 in Asia9. Remarkably, the overall incidence 
of pneumonia hospitalization with influenza was 
1.5/10,000 in the United States. Influenza and 
bacterial pneumonia combination is the first cause of 
death from infectious disease in the United States10. 
Last year according to expert opinion, some CAP 
patients with confirmed influenza had sudden 
dyspnea and unusual radiological pattern in favour of 
pulmonary embolism. 
We have not found any parallel investigation on 
Influenza in CAP patients in Iran, and no studies 
have reported trends that are more recent. Therefore, 
we designed this research to emphasize on the role of 
influenza in CAP patients, to introduce the 
significant use of Real-time PCR assay in such 
individuals, and to improve the patient’s care in 
Loghman Hakim Hospital, Tehran, Iran. However, 
the goal of our study was to determine frequency of 
influenza-A-H1N1 in patients with CAP and in all 
suspected 29 patients. 
Methods 
Study Design and Inclusion Criteria: In this cross-
sectional study, 61 patients with flu like symptoms 
(started within three days) were evaluated. Clinical 
presentation and chest x-ray of 29 patients were 
compatible with CAP. Patients were over 18 years old. 
Collection of Samples: Under the supervision of an 
infectious specialist, respiratory specimens collected 
within 12 hours of enrolment. A nasal sample using 
plastic-shafted Dacron swabs took from selected 
patients. Transferring to a VTM microtube, the 
specimens then vortexed to release the particles 
adhering to the Dacron swab and obtain a final volume 
of 0.5 to 1 ml. Furthermore, blood, urine and 
endotracheal aspirates collected before starting 
antibiotics and antivirals. 
Endotracheal aspirates and sputums were sent for 
semi-quantitative cultures, which were considered 
positive with moderate to dense growths of bacteria 
and few epithelial cells seen on Gram stain 
examination (≤10 per high-power field). Blood 
cultures were incubated aerobically and anaerobically 
in three sets. Serum and urine samples were tested in 
substantial laboratory panels. 
Real-Time PCR Amplification Technique for Virus 
Detection: At the first step, specimens went under 
RNA extraction using DynaBio™ viral nucleic acid 
(DNA\RNA) extraction kit. According to the 
manufacturer’s structure, we used cDNA synthesis kit 
YT4502 M-MLV reverse transcriptase to convert 
RNA to cDNA. In the last step, we used primer 
design-swine H1N1 influenza human pandemic strain-
genesig advanced kit (England) for performing 
quantitative Real-time PCR assay. The reaction 
consisted of 10 µl of Master Mix 1x, one µl of M1-
Primer (20 pmol), one µl of endogenous control 
primer-probe mix, four µl of the template and four µl 
of RNAse/DNAse free water. The concluding volume 
was 20 µl, and the cycles were as follows: First-hold at 
95ºc for 5 minutes, 40 cycles of 95ºc for 10 seconds 
and 60ºc for 60 seconds. 
Statistical Analysis: Data analysed using the 
statistical package for social sciences (SPSS) version 
22 and the p-value under 0.05 considered statistically 
significant. Continuous data were analysed by 
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student’s t-test if the data were normally distributed 
(using Kolmogorov-Smirnov); otherwise, the Mann–
Whitney U-test applied. Categorical data compared 
using Pearson’s chi-square test. Baseline 
demographic variables and screening measure 
variables compared across groups using chi-square 
for categorical variables and one-factor ANOVA for 
continuous variables. 
This study was conducted in line with the Helsinki 
ethical principle and was performed after obtaining 
the approval of the Ethics Committee for Research in 
the Faculty of Medicine of Shahid Beheshti 
University of Medical Sciences (code: 
IR.SBMU.REC.1395.79). All information gathered 
from patients is confidential to the researcher. Other 
personal information of individuals is also kept under 
the confidentiality law practice process. 
Results 
From November 22, 2016, to June 21, 2017, 61-
suspected cases of seasonal Influenza admitted to the 
emergency room of Loghman Hakim Hospital in 
Tehran. Of the 61 patients, 29 of them had the 
inclusion criteria of this study. None of them had 
vaccination profile against influenza. 
Summarized demographics: The admission peak 
was in February (48.3%) (Figure 1). Majority of our 
patients (51.7%) were male. The mean age of patients 
was 60.07 ± 20.94 years, with a minimum of 25 years 
and a maximum of 92 years. The highest number of 
participants related to the age group of 71-80 years 
and secondarily to the age group of 31-40 years. 
(Table 1). 
Laboratory panels, Clinical manifestations: In this 
study, five patients required the use of mechanical 
ventilation and the average number of days needed to 
use it was 4.57 ± 17.80 days. These five patients 
became infected due to bacterial pneumonia and had 
symptoms consistent with CAP. An endotracheal 
aspirate was requested for them. The bacteriological 
panel result was two Acinetobacter spp. and one 
Staphylococcus aureus cases (p<0.001). None of these 
five patients were positive for influenza. Radiological 
findings of patients have been demonstrated in Table 2 
(p=.041). Consolidation was the uppermost sign 
(44.8%). 
Along with our research, head nurse of infection 
control committee, performed rapid test in 61 
suspected cases of influenza admitted to the 
emergency room (not ward) and seven samples 
(13.72%) were positive for influenza. This result was 
positive in two cases out of 29 confirmed CAP 
patients. In other words, two out of seven positive 
influenza subjects required hospitalization and 
 
 
Figure 1. Admission time of this study’s participants. 
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eventually remaining five patients were managed as 
outpatient.  
Based on Quantitative Real-Time PCR testing in 
patients with CAP, five patients had H1N1-A 
influenza viral loads. However, according to the kit 
protocol, samples of more than 30 viral copies/ml are 
considered positive for the influenza-A-H1N1 virus. 
For the two samples (6.89%) mentioned in the 
preceding paragraph, more than 30 copies/ml of the 
Influenza H1N1 virus was obtained in their 
respiratory tract (Figure 2). 
Management of patients: Out of 61 cases suspected 
of influenza, 32 (43.13%) patients with flu-like 
syndrome discharged from the hospital after treatment. 
In the rest 29 confirmed CAP patients, the most 
common findings were fever and chills, coughing and 
confusion (15 cases, 29.41%) (Table 3). No case of 
admission to the intensive care unit was found.  
From the point of empiric treatment, the highest 
antibiotic combination was Ceftriaxone and 
Azithromycin (Table 4). A total of 31.3% of patients 
received empiric oseltamivir therapy. Duration of 
antibiotic therapy was longer than a CAP antibiotic 
regimen. According to the CURB65 score results, 89.7 
% had a score of two, 6.9% had a score of three, and 
3.4% had a score of four. In the two influenza-A-
Table 1: Laboratory panels, vital signs, mortality scores and demographics of CAP patients. 











White Blood Count(x1000) 20.06 ± 4.45 6.65 ± 3.46 10.2± 4.38 .002*** 
C-reactive protein (CRP) (mg/dl) 19.76± 34.23 55.6 ± 73.96 66.05± 51.46 .353 
Platelet (x1000/mm3) 250.66± 174.24 312 ± 117.37 210.13 ± 85.04 .326 
Aspartate aminotransferase (AST) 71.66± 21.12 58.5 ± 50.2 59.50 ± 84.63 .969 
Ratio of Lymphocytes 17.20± 11.83 32.1 ± 19.56 16.99 ± 9.45 .156 
Ratio of Neutrophils 79.26± 14.83 61.15 ± 27.22 74.37± 11.33 .291 
Ratio of 
Eosinophil/Basophil/Monocytes 
3.63 ± 3.69 6.75 ± 7.56 8.63± 5.39 .318 
Lactate dehydrogenase (LDH) 526 ± 310.98 584 ± 174.07 684 ± 672.5 .908 
Blood Urea Nitrogen (BUN) 36.91± 29.14 11.91 ± 5.61 17.98 ± 7.5 .021*** 
Creatinine 1.6± 0.6 0.9 ± 0.28 1.21± 0.38 .161 
Total Protein 5.9 ± 1.97 6.26±0.97 6.32± 9.39 .698 
Albumin 3.56± 0.95 3.73±0.25 3.76± 0.18 .658 
H1N1 Viral Load (Copy/µl) 0 563 ± 49.49 1.04± 3.95 .000*** 
Vital Signs and Mortality scores 
Systolic Blood Pressure 100 ± 10 115 ± 7.07 131.08 ± 21.31 .046*** 
Diastolic Blood Pressure 63.33± 15.27 70 79.56± 12.60 .098 
Respiratory Rate 23.33± 10.21 17 ± 4.24 17.78 ± 2.92 .096 
CURB65 score* 3± 1 2 2.04 ± 0.2 .000*** 
Pneumonia Mortality Rates 0.022 
Demographics 
Age 45.67 ± 25.4 34.50 ± 7.77 64 ± 19.37 .067 
Males 100 % 100 % 41.66 % .060 
Days of Mechanical Ventilation 8 ± 2.64 0 4.52 ± 19.61 .893 
Prevalence of Influenza 0.06 per 7 months 
Incidence of Influenza 67/1000/year 
Risk of influenza 1.125, CI** 95 % 
*Abbreviation: CURB-65, confusion of new onset, blood urea nitrogen >7 mmol/l, respiratory rate ≥30 breaths per minute, 
blood pressure <90 mmHg systolic or ≤60 mmHg diastolic, age≥65 years. 
**CI= Confidence Interval 
***p values are significantly different. 
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H1N1 positive patients, the CURB65 score was 
reported as two and three, respectively. Eventually, 
89.7% gained complete recovery, 6.9% deceased, 
and 3.4% left the hospital with personal 
responsibility. 
Discussion 
This study was conducted in Loghman Hakim 
Hospital, Tehran, Iran for a seven-month period. 
According to the statistics of previous years in this 
educational and therapeutic center, the number of 
clients with influenza-like symptoms in emergency 
triage were reported as 35 people in 2014, 40 in 2015 
and 45 in 2016 years. Finally, in our study 61 patients 
presented influenza-like illness symptoms started 
within three days.  
 
Figure 2. Quantitative Real-time PCR results based on M and N genes. 
 
Table 2: Radiologic patterns of CAP patients. 
Radiography Results Frequency Percent 
 
Consolidation 9 31 
Consolidation 4 13.8 
Consolidation+Plural effusion+Cavity Formation 2 6.9 
Peribronchial Nodules 4 13.8 
Peribronchial Nodules+Ground Glass Opacity 4 13.8 
Peribronchial Nodules+Ground Glass Opacity+Random 
Nodules 
1 3.4 
Peribronchial Nodules+Ground Glass Opacity+Infiltration 1 3.4 
Peribronchial Nodules+Ground Glass Opacity+Pleural 
Effusion 
1 3.4 
Random Nodules 2 6.9 
Peribronchial Nodules 1 3.4 
Ground Glass Opacity 1 3.4 
Pleural Effusion+Consolidation 1 3.4 
Total 29 100.0 
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Here we studied on 29 suspected cases of influenza 
presented with community-acquired pneumonia. The 
majority of our patients were males (51.7%), and this 
was consistent with a Chinese study (71%)11. 
Nevertheless, in a study published in Argentina in an 
outbreak season, H1N1 influenza was prevalent 
among women12. According to world health 
organisation (WHO) reports in the developed 
countries, the incidence of seasonal flu in all age 
groups is more prevalent in men (more than 60% in 
the United States)13. The women make robust 
antibodies in higher titter against influenza viruses, 
so they are more resistant to influenza than men14. 
In this study, the mean age of patients was 60.07 ± 
20.94 years. The highest number of referrals was 
primarily related to the age group 71-80 years and 
secondarily to the age group of 31-40 years. Two cases 
that were positive for the influenza virus had 29 and 
40 years of age. One of the characteristics of 
influenza-A-H1N1 flu is infecting children and 
adults15 and only 5% of influenza-A-H1N1 cases 
around the world had over 65 years16-18. This age 
distribution indicates relative immunity in the adult 
population. Studies have shown that more than 33% of 
Table 3: Presented manifestations of CAP patients at the time of admission in the Loghman Hakim Hospital. 
On admission symptoms Frequency Percent 
 Flu-like syndrome 32 52.45 
 
A cough, Phlegm, Fever, and Chills 7 13.72 
A cough, Phlegm, Fever and Chills, Weakness and Narcosis, Nausea and Vomiting 1 1.96 
A cough, Phlegm, Fever, and Chills, Chest Pain 1 1.96 
 
A cough, Phlegm, Fever, and Chills, Headache, Dizziness 1 1.96 
 
A cough, Phlegm, Fever and Chills, Loss of Consciousness, Sepsis 1 1.96 
 
A cough, Phlegm, Fever, and Chills, Abdominal pain 1 1.96 
 
A cough, Phlegm, Fever, and Chills, Imbalance 1 1.96 
 
A cough, Phlegm, Fever and Chills, Shortness of Breath 1 1.96 
 
A cough, Phlegm, Fever and Chills, Shortness of Breath, Myalgia 1 1.96 
 
Weakness and Narcosis, Loss of Consciousness, Pinpoint pupil, Mouth Bloodshed, Methadone 1 1.96 
 
Toxicity   
Nausea and Vomiting, Headache, Co toxicity 1 1.96 
 
Nausea and Vomiting, Abdominal pain, Pancreatitis 1 1.96 
 
Nausea and Vomiting, Hypoxic, Cyanosis 1 1.96 
 
Chest Pain 1 1.96 
 
A cough, Phlegm, Fever and Chills, Tachypnea, ARDS, Decreased level of Hemoglobin, 1 1.96 
 
Vasculitis   
Loss of Consciousness 1 1.96 
 
Seizure and tongue bite with incontinency 1 1.96 
 
Cold symptoms 1 1.96 
 
Spondylodiscitis, Device infection, Edema, Urine incontinency 1 1.96 
 
Craniotomy Postop Infection 1 1.96 
 
ARDS, Feet Erythematous, Sarcoidosis, Pancytopenia 1 1.96 
 
Shortness of Breath, Weakness and Narcosis, Fever and Chills 1 1.96 
 
Shortness of Breath, Fever and Chills, Chest Pain 1 1.96 
 
Total 61 100.0 
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adults over the age of 60 have cross-reactive 
antibodies against influenza A (H1N1) 2009 virus19. 
In the study, one of positive influenza-A-H1N1 
patients were admitted to the ward and the other one 
in ICU. Both patients presented with cough, phlegm, 
fever and chills. Studies have shown that 2-5% of 
confirmed cases of influenza-A-H1N1 in the United 
States, Canada and 6% of confirmed cases in Mexico 
require hospitalization17, which are consistent with 
the statistics presented in this study. 
Diagnosis of viruses in less than 10% of CAP cases 
in our study is consistent with the results of many 
studies20. Here, the results of two different assays  
(Rapid Antigen Test and Quantitative Real-Time 
PCR test) were similar. As before mentioned, 61 
suspected cases of influenza ware temporarily 
admitted in emergency service. Infection control 
committee of the hospital checked all of them with 
rapid test for influenza which seven cases were 
positive. Five out of them were discharged and two 
admitted remaining cases were the same two positive 
influenza cases with PCR in our study. In a meta-
analysis study on 159 published articles, the sensitivity 
and specificity of rapid influenza tests were 98% and 
34% respectively21. In recent years, the sensitivity and 
specificity of these tests were 68-79% and 99-100%, 
respectively22-24. In diagnosis of influenza, sensitivities 
and specificities of RT-PCR and other molecular 
assays are very high, compared to other FDA-cleared 
assays. However, false negative results can occur due 
to improper or poor clinical specimen collection or 
from poor handling of a specimen after collection and 
before testing. A negative result can also occur by 
testing a specimen that was collected when the patient 
was no longer shedding detectable influenza virus that 
may also occurred in our study. False positive results, 
although rare, can occur (due to lab contamination or 
other factors)25.  
Table 4: Antibiotic regimen of admitted CAP patients. 
Antibiotics Percent 
Missing Data 3.4 
None 6.9 
Clindamycin+ Vancomycin+ Pipractam+ Gentamicin + Ciprofloxacin 3.4 
Clindamycine+Vancomycin + Meropenem 3.4 
Ceftazidime+ Vancomycin 3.4 




Vancomycin+ Ciprofloxacin+ Ceftriaxone+ Meropenem+ Cotrimoxazole 3.4 
Vancomycin+ Ceftriaxone 6.9 
Vancomycin+ Ceftriaxone+ Meropenem+ Levofloxacin+ Cotrimoxazole 3.4 
Vancomycin+ Ceftriaxone+ Meropenem+ Levofloxacin 3.4 
Vancomycin+ Meropenem+ Levofloxacin 3.4 
Ceftriaxone+ Azithromycin 13.8 
Ceftriaxone+ Azithromycin+ Levofloxacin 3.4 
Ceftriaxone+ Meropenem+ Levofloxacin 3.4 
Ceftriaxone+ Levofloxacin 3.4 
Ceftriaxone+ Metronidazole+ Imipenem 3.4 
Azithromycin 6.9 
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In the following study, nine patients received empiric 
oseltamivir treatment. In accordance with the 
guidelines of the CDC, prompt empiric treatment 
with oseltamivir (oral), zanamivir (inhaled) or 
peramivir (IV) should be done in persons with 
suspected or confirmed influenza. They need to 
admission. Progressive, severe, complicated illness, 
regardless of previous health status, and/or patients at 
risk for severe diseasee26.  
In our study, the duration of antibiotic therapy was 
longer than a CAP antibiotic regimen and the most 
used antibiotic regimen in patients was Ceftriaxone 
plus Azithromycin. Between the two influenza-A-
H1N1 patients, the first one received the combination 
of levofloxacin and Tamiflu and the second one 
treated with the combination of Clindamycin, 
Vancomycin, Gentamicin and Ciprofloxacin. 
According to Harrison’s principle of medicine, 
empirical treatment for CAP admitted in ward is 
different and includes a respiratory fluoroquinolone 
(e.g., moxifloxacin or levofloxacin) or a β-lactam 
(e.g., ceftriaxone, ampicillin, cefotaxime, ertapenem) 
plus a macrolide (e.g., oral clarithromycin or 
azithromycin or IV azithromycin). Empirical 
treatment for admitteds in ICU includes  an 
antipneumococcal beta-lactam (cefotaxime, 
ceftriaxone, or ampicillin-
sulbactam) plus azithromycin or an 
antipneumococcal beta-lactam  plus a respiratory 
fluoroquinolone 27. 
In this study, diversity of antibiotic regimens, which 
was not based on recommended regimens in 
guidelines, showed the importance and requirement of 
antibiotic stewardship program in this hospital. 
Here, the radiological finding in confirmed cases of 
H1N1 was consolidation in a lobe.  
According to Mandell’s principles and practice of 
infectious disease 2015, pulmonary complications of 
influenza consist of primary viral pneumonia, 
secondary bacterial pneumonia, mixed viral and 
bacterial pneumonia and localized viral pneumonia 
(table 5). It seems that in our study most cases have 
radiologic patterns other than primary viral 
pneumonia4. 
In the recent years, Iranian Ministry of health 
distributed 300,000 to 400,000 influenza vaccines. 
Unfortunately, none of the patients in our study had 
been vaccinated before admission.  
Considering our research type as a cross-sectional and 
prospective study, we confronted with two limitations. 
Some patients did not have cooperation due to bad 
feeling of nasal swab sampling and we were only able 
to investigate the influenza A H1N1 virus due to 
limited funding for this project. 
Conclusion 
There was not any unusual symptoms and 
Table 5: Comparative features of pulmonary complications of influenza. 











Adults and children  Any associated with A 
or B 
?Normal 
Clinical history Relentless progression 
from classic 3 day 
influenza 
Improvement, then 
worsening after 3 day 
influenza 
Features of both 
primary and secondary 
pneumonia 
Continuation of 
classic 3 day 
syndrome 
Physical examination Bilateral findings, no 
consolidation 
Consolidation  consolidation Area of rales 









Chest radiography Bilateral findings Consolidation  consolidation Segmental infiltrate 
Detection of influenza 
virus 
Yes  Not always  Yes  Yes  
Response to 
antibiotics 
No  Yes  Often  No  
mortality High  Variable  variable Very low  
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unpredictable radiologic pattern in patients with 
influenza. Irrational prescription of antibiotics is a 
strong reason for the need to antibiotic stewardship 
program. Influenza cases requiring hospitalization, 
need to be empirically treated with anti-influenza 
drugs, but in our study low number of cases had been 
treated then more training about this subject should 
be given to residents in emergency ward. In addition, 
according to low number of vaccinated patients, 
more training and extensive advertise should be 
done. 
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